Clin2
NCT04792931Possibly a fitRecruiting

Study for adults with suspected autoimmune muscle disease

Idiopathic Inflammatory Myopathies

Part of Bones, joints & muscles, Brain & nervous system clinical trials.

This study looks at adults who may have an autoimmune (self-immune) muscle disease. It aims to better understand and evaluate this condition, which may help guide future diagnosis and care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • A clinician suspects you have an inflammatory autoimmune muscle problem
  • You have social security coverage/affiliation
  • You can understand the study and give informed consent
  • You are not pregnant or breastfeeding
  • You are able and willing to participate in the research

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06306547Not yet recruiting
Patient cohort study for inflammatory myositis

This study is creating a group of patients with idiopathic inflammatory myositis (a condition where your immune system attacks your muscles) to better understand the disease and improve care. It's open to adults ages 18 to 75 who have been diagnosed using specific medical guidelines.

NCT03092180Recruiting
Tests a treatment approach for certain muscle inflammation diseases

This trial looks at treatment strategies for people with idiopathic inflammatory myopathies, which are illnesses where the immune system attacks muscles. It may help improve how treatment is chosen and optimized for this group of conditions, but it specifically excludes several related muscle diseases.

São Paulo
NCT07284797Recruiting· Phase 1
Safety study for autoimmune disease and healthy volunteers

This trial is testing an experimental drug for safety in people with certain autoimmune diseases—like myositis, scleroderma, or Sjögren's disease—as well as in healthy volunteers. It aims to find out if the drug is safe enough to study further.

Melbourne
NCT07789015Not yet recruiting· Phase 3
Study of nerandomilast for active myositis

This study tests a new oral medication, nerandomilast, for people with active idiopathic inflammatory myopathies (a group of rare autoimmune diseases causing muscle weakness). It aims to see if the drug can reduce disease activity safely. Participants must have moderate-to-severe symptoms and be on standard treatments.

Phoenix, Arizona
NCT00017914Recruiting
Understanding muscle inflammation: adult and juvenile myositis study

This research study helps doctors better understand myositis—a group of rare diseases that cause muscle inflammation and weakness. Researchers collect blood samples, medical history, and sometimes muscle biopsies to learn more about what causes these conditions and how to treat them better.

Atlanta, Georgia
NCT05454527Recruiting
Biobank study follow-up for adults with inflammatory muscle disease

This study follows adults who have (or are being evaluated for) inflammatory muscle conditions to collect health data and genetic test information. It may help researchers better understand these diseases and improve future care.

Paris

Hear when a new Idiopathic Inflammatory Myopathies trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.